REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 59 filers reported holding REGULUS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $334,000 | -31.7% | 148,265 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $489,000 | +14.0% | 148,265 | -0.1% | 0.00% | 0.0% |
Q2 2016 | $429,000 | -38.0% | 148,444 | +48.7% | 0.00% | 0.0% |
Q1 2016 | $692,000 | -19.2% | 99,830 | +1.7% | 0.00% | 0.0% |
Q4 2015 | $856,000 | +33.5% | 98,174 | +0.2% | 0.00% | 0.0% |
Q3 2015 | $641,000 | -41.7% | 97,965 | -2.3% | 0.00% | 0.0% |
Q2 2015 | $1,099,000 | +45.6% | 100,312 | +125.1% | 0.00% | 0.0% |
Q1 2015 | $755,000 | +7.9% | 44,567 | +2.1% | 0.00% | 0.0% |
Q4 2014 | $700,000 | +154.5% | 43,651 | +8.3% | 0.00% | – |
Q3 2014 | $275,000 | -11.3% | 40,302 | +4.5% | 0.00% | – |
Q2 2014 | $310,000 | +21.6% | 38,556 | +36.1% | 0.00% | – |
Q1 2014 | $255,000 | +27.5% | 28,322 | +4.7% | 0.00% | – |
Q4 2013 | $200,000 | -22.8% | 27,052 | -1.5% | 0.00% | – |
Q3 2013 | $259,000 | +6.1% | 27,477 | +10.4% | 0.00% | – |
Q2 2013 | $244,000 | – | 24,885 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 327,350 | $943,000 | 0.99% |
DAFNA Capital Management LLC | 421,500 | $1,218,000 | 0.96% |
Rhenman & Partners Asset Management AB | 350,000 | $1,012,000 | 0.18% |
BOURGEON CAPITAL MANAGEMENT LLC | 70,704 | $204,000 | 0.13% |
Piermont Capital Management Inc. | 151,924 | $439,000 | 0.11% |
Virtus ETF Advisers LLC | 46,269 | $134,000 | 0.10% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 389,144 | $1,124,000 | 0.08% |
GLOBEFLEX CAPITAL L P | 80,637 | $233,000 | 0.06% |
South Dakota Investment Council | 900,000 | $2,601,000 | 0.06% |
FOX RUN MANAGEMENT, L.L.C. | 33,100 | $96,000 | 0.05% |